Barrord, Michelle; Ahmad, Syed; Patel, Sameer; Olowokure, Olugbenga; Sussman, Jeffrey; Smith, Milton; Poreddy, Sampath; Esslinger, Hope; Latif, Tahir; Choe, Kyuran; Kharofa, Jordan 2020. Patterns of Failure After Neoadjuvant Stereotactic Body Radiation Therapy or Fractionated Chemoradiation in Resectable and Borderline Resectable Pancreatic Cancer. Pancreas, 49 7, 941-946
N'Guessan, Kombo F; Davis, Harold W; Chu, Zhengtao; Vallabhapurapu, Subrahmanya D; Lewis, Clayton S; Franco, Robert S; Olowokure, Olugbenga; Ahmad, Syed A; Yeh, Jen Jen; Bogdanov, Vladimir Y; Qi, Xiaoyang 2020. Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. Molecular therapy : the journal of the American Society of Gene Therapy, 28 8, 1876-1886
Abou-Alfa, Ghassan K; Miksad, Rebecca A; Tejani, Mohamedtaki A; Williamson, Stephen; Gutierrez, Martin E; Olowokure, Olugbenga O; Sharma, Manish R; El Dika, Imane; Sherman, Matthew L; Pandya, Shuchi S 2019. A Phase Ib, Open-Label Study of Dalantercept, an Activin Receptor-Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma. The oncologist, 24 2, 161-e70
Ge, Chunmin; Vilfranc, Chrystelle L; Che, Lixiao; Pandita, Raj K; Hambarde, Shashank; Andreassen, Paul R; Niu, Liang; Olowokure, Olugbenga; Shah, Shimul; Waltz, Susan E; Zou, Lee; Wang, Jiang; Pandita, Tej K; Du, Chunying 2019. The BRUCE-ATR Signaling Axis Is Required for Accurate DNA Replication and Suppression of Liver Cancer Development. Hepatology (Baltimore, Md.), 69 6, 2608-2622
Kharofa, Jordan; Mierzwa, Michelle; Olowokure, Olugbenga; Sussman, Jeffrey; Latif, Tahir; Gupta, Anumeha; Xie, Changchun; Patel, Sameer; Esslinger, Hope; Mcgill, Brian; Wolf, Eric; Ahmad, Syed A 2019. Pattern of Marginal Local Failure in a Phase II Trial of Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy for Resectable and Borderline Resectable Pancreas Cancer. American journal of clinical oncology, 42 3, 247-252
Sanoff, Hanna K; Goldberg, Richard M; Ivanova, Anastasia; O'Reilly, Seamus; Kasbari, Samer S; Kim, Richard D; McDermott, Ray; Moore, Dominic T; Zamboni, William; Grogan, William; Cohn, Allen Lee; Bekaii-Saab, Tanios S; Leonard, Gregory; Ryan, Theresa; Olowokure, Olugbenga O; Fernando, Nishan H; McCaffrey, John; El-Rayes, Bassel F; Horgan, Anne M; Sherrill, Gary Bradley; Yacoub, George Hosni; O'Neil, Bert H 2018. Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancer. Cancer, 124 15, 3118-3126
Wakefield, Connor; Mehta, Parinda A; Corathers, Sarah; Geller, James; Gelfand, Michael; Olowokure, Olugbenga; Marsh, Rebecca A 2018. A First Report of Secondary Hemophagocytic Lymphohistiocytosis Associated With Papillary Thyroid Carcinoma. Journal of pediatric hematology/oncology, 40 2, e97-e98
Kim, Young; Stahl, Christopher C; Makramalla, Abouelmagd; Olowokure, Olugbenga O; Ristagno, Ross L; Dhar, Vikrom K; Schoech, Michael R; Chadalavada, Seetharam; Latif, Tahir; Kharofa, Jordan; Bari, Khurram; Shah, Shimul A 2017. Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria. Surgery, 162 6, 1250-1258
Wise-Draper, Trisha M; Moorthy, Ganesh; Salkeni, Mohamad A; Karim, Nagla Abdel; Thomas, Hala Elnakat; Mercer, Carol A; Beg, M Shalaan; O'Gara, Sue; Olowokure, Olugbenga; Fathallah, Hassana; Kozma, Sara C; Thomas, George; Rixe, Olivier; Desai, Pankaj; Morris, John C 2017. A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid Malignancies. Targeted oncology, 12 3, 323-332
Xia, Brent T; Fu, Baojin; Wang, Jiang; Kim, Young; Ahmad, S Ameen; Dhar, Vikrom K; Levinsky, Nick C; Hanseman, Dennis J; Habib, David A; Wilson, Gregory C; Smith, Milton; Olowokure, Olugbenga O; Kharofa, Jordan; Al Humaidi, Ali H; Choe, Kyuran A; Abbott, Daniel E; Ahmad, Syed A 2017. Does radiologic response correlate to pathologic response in patients undergoing neoadjuvant therapy for borderline resectable pancreatic malignancy? Journal of surgical oncology, 115 4, 376-383
Agarwal, Rishi; Sendilnathan, Arun; Siddiqi, Nabeela Iffat; Gulati, Shuchi; Ghose, Abhimanyu; Xie, Changchun; Olowokure, Olugbenga Olanrele 2016. Advanced biliary tract cancer: clinical outcomes with ABC-02 regimen and analysis of prognostic factors in a tertiary care center in the United States. Journal of gastrointestinal oncology, 7 6, 996-1003
Deeb, Ayham; Haque, Sulsal-Ul; Olowokure, Olugbenga 2015. Pulmonary metastases in pancreatic cancer, is there a survival influence? Journal of gastrointestinal oncology, 6 3, E48-51
O'Neil, B H; Scott, A J; Ma, W W; Cohen, S J; Leichman, L; Aisner, D L; Menter, A R; Tejani, M A; Cho, J K; Granfortuna, J; Coveler, A L; Olowokure, O O; Baranda, J C; Cusnir, M; Phillip, P; Boles, J; Nazemzadeh, R; Rarick, M; Cohen, D J; Radford, J; Fehrenbacher, L; Bajaj, R; Bathini, V; Fanta, P; Berlin, J; McRee, A J; Maguire, R; Wilhelm, F; Maniar, M; Jimeno, A; Gomes, C L; Messersmith, W A 2015. A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 26 9, 1923-9
O'Neil, B H; Scott, A J; Ma, W W; Cohen, S J; Leichman, L; Aisner, D L; Menter, A R; Tejani, M A; Cho, J K; Granfortuna, J; Coveler, L; Olowokure, O O; Baranda, J C; Cusnir, M; Phillip, P; Boles, J; Nazemzadeh, R; Rarick, M; Cohen, D J; Radford, J; Fehrenbacher, L; Bajaj, R; Bathini, V; Fanta, P; Berlin, J; McRee, A J; Maguire, R; Wilhelm, F; Maniar, M; Jimeno, A; Gomes, C L; Messersmith, W A 2015. A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 26 12, 2505
Rixe, Olivier; Puzanov, Igor; LoRusso, Patricia M; Cohen, Roger B; Morris, John C; Olowokure, Olugbenga O; Yin, Jian Y; Doroumian, Séverine; Shen, Liji; Olszanski, Anthony J 2015. Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies. Anti-cancer drugs, 26 7, 785-92
Yellu, Mahender R; Olowokure, Olugbenga 2015. Simultaneous presentation of pancreatic cancer in a genetically unrelated couple. BMJ case reports, 2015 ,
Yellu, Mahender; Deeb, Ayham; Olowokure, Olugbenga 2015. Overview of Recent Trends in the Management of Metastatic Anal Cancer. World journal of oncology, 6 1, 311-315
Beg, Muhammad Shaalan; Dwivedi, Alok Kumar; Ahmad, Syed Arif; Ali, Sadia; Olowokure, Olugbenga 2014. Impact of diabetes mellitus on the outcome of pancreatic cancer. PloS one, 9 5, e98511
Haque, Sulsal; Choe, Kyuran; Olowokure, Olugbenga 2014. Bilateral above knee amputations after prolonged exposure to sorafenib and trebananib. Journal of gastrointestinal oncology, 5 6, E109-12
Olowokure, Olugbenga; Qi, Xiaoyang 2014. Pancreatic cancer: current standards, working towards a new therapeutic approach. Expert review of anticancer therapy, 14 5, 495-7
Shi, Patricia Ann; Manwani, Deepa; Olowokure, Olugbenga; Nandi, Vijay 2014. Serial assessment of laser Doppler flow during acute pain crises in sickle cell disease. Blood cells, molecules & diseases, 53 4, 277-82
Singeltary, Brian; Ghose, Abhimanyu; Sussman, Jeffrey; Choe, Kyuran; Olowokure, Olugbenga 2014. Durable response with a combination of imatinib and sorafenib in KIT exon 17 mutant gastrointestinal stromal tumor. Journal of gastrointestinal oncology, 5 1, E27-9
Olowokure, Olugbenga; Torregroza-Sanchez, Maria Patricia; Bedoya-Apraez, Ivan Dario 2013. Gemcitabine plus Nab-Paclitaxel with chemoradiation in locally advanced pancreatic cancer (LAPC). Journal of gastrointestinal oncology, 4 2, E16-8
Grewal, Sanjeet S; McClaine, Rebecca J; Schmulewitz, Nathan; Alzahrani, Mohammed A; Hanseman, Dennis J; Sussman, Jeffery J; Smith, Milton; Choe, Kyuran A; Olowokure, Olugbenga; Mierzwa, Michelle; Ahmad, Syed A 2011. Factors associated with recidivism following pancreaticoduodenectomy. HPB : the official journal of the International Hepato Pancreato Biliary Association, 13 12, 869-75
Jeske, Stephanie; Tagawa, Scott T; Olowokure, Olugbenga; Selzer, Jodi; Giannakakou, Paraskevi; Nanus, David M 2010. Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancer. Urologic oncology, ,
Olowokure, O; Fishman, M; Cromwell, C; Aledort, L 2009. DDAVP for von Willebrand menorrhagia--severe hyponatraemia, haemolysis, seizure, coma.!! Caution. Haemophilia : the official journal of the World Federation of Hemophilia, 15 3, 837
O'Neil B.H.;Scott A.J.;Ma W.W.;Cohen S.J.;Leichman L.;Aisner D.L.;Menter A.R.;Tejani M.A.;Cho J.K.;Granfortuna J.;Coveler L.;Olowokure O.O.;Baranda J.C.;Cusnir M.;Phillip P.;Boles J.;Nazemzadeh R.;Rarick M.;Cohen D.J.;Radford J.;Fehrenbacher L.;Bajaj R.;Bathini V.;Fanta P.;Berlin J.;McRee A.J.;Maguire R.;Wilhelm F.;Maniar M.;Jimeno A.;Gomes C.L.;Messersmith W.A. 12-01-2015. A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine ve Annals of Oncology, 26 12, 2505
Bekaii-Saab T.; Cohn A.; El-Rayes B.; Fernando N.; Goldberg R.M.; Grogan W.; Horgan A.; Ivanova A.; Kasbari S.; Kim R.; McCaffrey J.; McDermott R.; Moore D.; Olowokure O.; O'Neil B.; O'Reilly S.; Ryan T.; Sanoff H.; Sherrill G.; Yacoub G. 10-01-2016. A multi-center, randomized, double-blind phase II trial of FOLFIRI + regorafenib or placebo for pati Annals of Oncology, 27 , vi153
Yellu M.;Kamireddy C.;Olowokure O. 09-27-2017. Pancreatic cancer epidemiology and environmental risk factors Current and Emerging Therapies in Pancreatic Cancer, , 1-22
O'Neil B.H.;Scott A.J.;Ma W.W.;Cohen S.J.;Aisner D.L.;Menter A.R.;Tejani M.A.;Cho J.K.;Granfortuna J.;Coveler A.L.;Olowokure O.O.;Baranda J.C.;Cusnir M.;Phillip P.;Boles J.;Nazemzadeh R.;Rarick M.;Cohen D.J.;Radford J.;Fehrenbacher L.;Bajaj R.;Bathini V.;Fanta P.;Berlin J.;McRee A.J.;Maguire R.;Wilhelm F.;Maniar M.;Jimeno A.;Gomes C.L.;Messersmith W.A. 06-18-2016. Erratum: A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemci Annals of Oncology, 27 6, 1180
Braverman A.S.;Nehra A.;Olowokure O.;Raftery T.;Gillette P.;Weedon J.;Olivier T.;Belyayeva I.;Deitch J. 06-01-2008. Perforator and axial venous insufficiency in sickle cell disease patients with and without leg ulcer Journal for Vascular Ultrasound, 32 2, 79-81
Agarwal R.;Sendilnathan A.;Siddiqi N.;Gulati S.;Ghose A.;Xie C.;Olowokure O. 01-01-2016. Advanced biliary tract cancer: Clinical outcomes with ABC-02 regimen and analysis of prognostic fact Journal of Gastrointestinal Oncology, 7 6, 996-1003
Deeb A.;Haque S.;Olowokure O. 01-01-2015. Pulmonary metastases in pancreatic cancer, is there a survival influence? Journal of Gastrointestinal Oncology, 6 3, E48-E51
Manwani D.;Chen G.;Carullo V.;Serban S.;Olowokure O.;Jang J.;Huggins M.;Cohen H.W.;Billett H.;Atweh G.F.;Frenette P.S.;Shi P.A. 01-01-2015. Single-dose intravenous gammaglobulin can stabilize neutrophil Mac-1 activation in sickle cell pain American Journal of Hematology, 90 5, 381-385
Yellu M.;Deeb A.;Olowokure O. 01-01-2015. Overview of recent trends in the management of metastatic anal cancer CJAM Canadian Journal of Addiction Medicine, 6 1, 311-315
Haque S.;Choe K.;Olowokure O. 01-01-2014. Bilateral above knee amputations after prolonged exposure to sorafenib and trebananib Journal of Gastrointestinal Oncology, 5 6, E109-E112
Singeltary B.;Ghose A.;Sussman J.;Choe K.;Olowokure O. 01-01-2014. Durable response with a combination of imatinib and sorafenib in KIT exon 17 mutant gastrointestinal Journal of Gastrointestinal Oncology, 5 1,
Olowokure O.;Torregroza-Sanchez M.;Bedoya-Apraez I. 01-01-2013. Gemcitabine plus nab-paclitaxel with chemoradiation in locally advanced pancreatic cancer (LAPC) Journal of Gastrointestinal Oncology, 4 2,
